Universal Assay Platform Allows Rapid Blood Grouping
By HospiMedica International staff writers Posted on 28 Mar 2017 |

Image: A novel paper strip performs ABO and Rh group multiplex antigen assays (Photo courtesy of Hong Zhang).
A new study describes how a paper-based point-of-care assay could provide fast and reliable blood group testing at the patient’s bedside.
Developed by researchers at Third Military Medical University, the paper-based assay uses immobilized antibodies and bromocresol green dye for rapid and reliable blood grouping, where dye-assisted color changes corresponding to distinct blood components provide a visual readout for each antigen (A, B, and Rhesus). The researchers also developed a machine-learning method that can classify spectral plots corresponding to the color changes, which enables reproducible automatic grouping.
The assay identifies ABO antigens and five major Rhesus antigens within 30 seconds using small volumes (100 μl) of whole blood, thus allowing simultaneous forward and reverse ABO blood grouping within two minutes through on-chip plasma separation, and all without centrifugation. When tested with optimized operating parameters, the dye-assisted paper assay exhibited comparable accuracy and reproducibility to the classical gel-card assays in grouping 3,550 human blood samples, with more than 99.9% accuracy. The study was published on March 15, 2017, in Science Translational Medicine.
“Fast and simultaneous forward and reverse blood grouping has long remained elusive. Forward blood grouping detects antigens on red blood cells, whereas reverse grouping identifies specific antibodies present in plasma,” concluded lead author Hong Zhang, PhD, and colleagues. “The paper strip could be used in war zones or remote areas where there are no labs to test patients’ blood types. O blood is currently used in these contexts, but supplies are limited.”
There are four major blood groups determined by the presence or absence of two antigens (A and B) on the surface of red blood cells (RBCs). Group A has only the A antigen on RBCs, and B antibody in the plasma; Group B has only the B antigen on RBCs, and A antibody in the plasma; Group AB has both A and B antigens on RBCs, but neither A nor B antibody in the plasma; and Group O has neither A nor B antigens on RBCs, but both A and B antibody in the plasma. In addition to the A and B antigens, there is a third antigen called the rhesus (Rh) factor, which can be either present (+) or absent (–). The universal red cell donor has Type O– blood type, and the universal plasma donor has Type AB+ blood type.
Developed by researchers at Third Military Medical University, the paper-based assay uses immobilized antibodies and bromocresol green dye for rapid and reliable blood grouping, where dye-assisted color changes corresponding to distinct blood components provide a visual readout for each antigen (A, B, and Rhesus). The researchers also developed a machine-learning method that can classify spectral plots corresponding to the color changes, which enables reproducible automatic grouping.
The assay identifies ABO antigens and five major Rhesus antigens within 30 seconds using small volumes (100 μl) of whole blood, thus allowing simultaneous forward and reverse ABO blood grouping within two minutes through on-chip plasma separation, and all without centrifugation. When tested with optimized operating parameters, the dye-assisted paper assay exhibited comparable accuracy and reproducibility to the classical gel-card assays in grouping 3,550 human blood samples, with more than 99.9% accuracy. The study was published on March 15, 2017, in Science Translational Medicine.
“Fast and simultaneous forward and reverse blood grouping has long remained elusive. Forward blood grouping detects antigens on red blood cells, whereas reverse grouping identifies specific antibodies present in plasma,” concluded lead author Hong Zhang, PhD, and colleagues. “The paper strip could be used in war zones or remote areas where there are no labs to test patients’ blood types. O blood is currently used in these contexts, but supplies are limited.”
There are four major blood groups determined by the presence or absence of two antigens (A and B) on the surface of red blood cells (RBCs). Group A has only the A antigen on RBCs, and B antibody in the plasma; Group B has only the B antigen on RBCs, and A antibody in the plasma; Group AB has both A and B antigens on RBCs, but neither A nor B antibody in the plasma; and Group O has neither A nor B antigens on RBCs, but both A and B antibody in the plasma. In addition to the A and B antigens, there is a third antigen called the rhesus (Rh) factor, which can be either present (+) or absent (–). The universal red cell donor has Type O– blood type, and the universal plasma donor has Type AB+ blood type.
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more